Literature DB >> 18070198

Activity of different phospholipids in attenuating hyperactivity in bladder irritation.

Pradeep Tyagi1, Michael Chancellor, Naoki Yoshimura, Leaf Huang.   

Abstract

OBJECTIVE: To evaluate the effect of liposomes prepared from various natural and synthetic lipids in a rat bladder injury model in the absence or the presence of cholesterol and to elucidate the key structural elements necessary for the efficacy of liposomes required for alleviating bladder hyperactivity.
MATERIALS AND METHODS: The intravesical pressure was recorded using a transurethral catheter in adult female Sprague-Dawley rats anaesthetized with urethane (1.0 g/kg subcutaneously). Continuous cystometrograms (CMGs) were obtained by slowly filling the bladder with solutions of varying compositions after obtaining a baseline CMG with saline. Rat urothelium was injured with protamine sulphate (PS) and irritated by subsequent infusion of KCl (500 mm) for 1 h. Thereafter, liposomes prepared in KCl using several natural and synthetic phospholipids were infused for 2 h. The percentage reduction in bladder contraction frequency (BCF) was used as a comparative variable for judging the activity of different phospholipids.
RESULTS: Exposure of rat bladder to sequential infusion of PS and KCl increased its BCF and empty liposomes of uncharged zwitterionic phospholipids markedly attenuated the PS-induced irritation and decreased the raised BCF. But empty liposomes prepared with either cationic or anionic charged lipids were not able to achieve the same effect. Addition of cholesterol did not significantly increase their efficacy. Optimal efficacy of liposomes was achieved with phosphatidylcholines with longer acyl chains and saturation in only one of the two acyl chains.
CONCLUSIONS: These in vivo studies show that phospholipids attenuate the bladder irritation from KCl after PS-induced bladder injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070198     DOI: 10.1111/j.1464-410X.2007.07334.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

Review 1.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 2.  Nanotechnology in urology.

Authors:  Shihua Jin; Vinod Labhasetwar
Journal:  Urol Clin North Am       Date:  2009-05       Impact factor: 2.241

3.  Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells.

Authors:  J Nirmal; A S Wolf-Johnston; M B Chancellor; P Tyagi; M Anthony; J Kaufman; L A Birder
Journal:  Int Urol Nephrol       Date:  2014-05-30       Impact factor: 2.370

4.  Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation.

Authors:  Kenneth M Peters; Deborah Hasenau; Kim A Killinger; Michael B Chancellor; Michele Anthony; Jonathan Kaufman
Journal:  Int Urol Nephrol       Date:  2014-09-11       Impact factor: 2.370

Review 5.  Interstitial cystitis intravesical therapy.

Authors:  Tanya Ha; Jie Hua Xu
Journal:  Transl Androl Urol       Date:  2017-07

Review 6.  Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome.

Authors:  Pradeep Tyagi; Mahendra P Kashyap; Naoki Kawamorita; Tsuyoshi Yoshizawa; Michael Chancellor; Naoki Yoshimura
Journal:  ISRN Pharmacol       Date:  2014-01-15

Review 7.  The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer.

Authors:  Laura Douglass; Mark Schoenberg
Journal:  Bladder Cancer       Date:  2016-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.